Prostate cancer (PCa) is the most common noncutaneous malignancy in men and is the
second leading cause of cancer mortality in men in the United States. Current practice …

Quality is currently recognized as the pre-requisite for delivering the clinical benefits
expected by magnetic resonance imaging (MRI)-informed prostate biopsy (MRI-i-PB) in …

Objectives Primary objectives: to determine whether local anaesthetic transperineal prostate
(LATP) biopsy improves the detection of clinically significant prostate cancer (csPCa) …

In prostate cancer, fusion biopsy, which couples magnetic resonance imaging (MRI) with
transrectal ultrasound (TRUS), poses the basis for targeted biopsy by allowing the …

Background To test the efficacy of emotion‐centered (EC) versus fact‐centered (FC) written
medical information for prostate biopsy to alleviate pain and anxiety in a randomized …

Prostate cancer screening often relies on cost-intensive MRIs and invasive needle biopsies.
Transrectal ultrasound imaging, as a more affordable and non-invasive alternative, faces the …

Background Transperineal Prostate Biopsy (TPB) is a commonly used technique for the
diagnosis of prostate cancer due to growing concerns related to infectious complications …

Background: Magnetic resonance imaging (MRI)/ultrasound targeted biopsy has frequently
been used together with a 12-core systematic biopsy for prostate cancer screening in the …

Introduction Transperineal (TP) biopsy has recently replaced the transrectal ultrasound
(TRUS) approach as the ideal method of biopsy in the United Kingdom with growing trends …

The prostate cancer pathway has evolved rapidly over the last decade responding to
evidence‐based recommendations. These changes were accelerated further over the last 5 …